Balyasny Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-610,571
| Closed | -$92.3M | – | 3079 |
|
|
2022
Q3 | $92.3M | Buy |
610,571
+276,732
| +83% | +$41.8M | 0.28% | 55 |
|
|
2022
Q2 | $48.6M | Buy |
+333,839
| New | +$48.6M | 0.16% | 116 |
|
|
2021
Q4 | – | Sell |
-34,446
| Closed | -$4.79M | – | 2507 |
|
|
2021
Q3 | $4.79M | Buy |
+34,446
| New | +$4.79M | 0.02% | 687 |
|
|
2021
Q1 | – | Sell |
-13,627
| Closed | -$1.17M | – | 2070 |
|
|
2020
Q4 | $1.17M | Buy |
+13,627
| New | +$1.17M | 0.01% | 842 |
|
|
2019
Q4 | – | Sell |
-122,231
| Closed | -$5.1M | – | 1498 |
|
|
2019
Q3 | $5.1M | Buy |
122,231
+24,890
| +26% | +$1.04M | 0.04% | 478 |
|
|
2019
Q2 | $4.26M | Buy |
+97,341
| New | +$4.26M | 0.03% | 553 |
|
|
2019
Q1 | – | Sell |
-264,861
| Closed | -$9.8M | – | 1676 |
|
|
2018
Q4 | $9.8M | Buy |
264,861
+257,659
| +3,578% | +$9.53M | 0.07% | 333 |
|
|
2018
Q3 | $270K | Sell |
7,202
-7,005
| -49% | -$263K | ﹤0.01% | 1307 |
|
|
2018
Q2 | $561K | Buy |
+14,207
| New | +$561K | ﹤0.01% | 1139 |
|